<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2022.1089886</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Multi-dimensional characterization of neuropsychiatric disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Peng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1032207/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Shijie</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/649280/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Xiang</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/325247/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lv</surname> <given-names>Jinglei</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/976216/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Automation, Northwestern Polytechnical University</institution>, <addr-line>Xi&#x00027;an</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Research and Development Institute of Northwestern Polytechnical University in Shenzhen</institution>, <addr-line>Shenzhen</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Center for Advanced Medical Computing and Analysis (CAMCA), Department of Radiology, Massachusetts General Hospital and Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>School of Biomedical Engineering and Brain and Mind Center, University of Sydney</institution>, <addr-line>Sydney, NSW</addr-line>, <country>Australia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Vince D. Calhoun, Georgia State University, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Xiang Li <email>xli60&#x00040;mgh.harvard.edu</email></corresp>
<corresp id="c002">Jinglei Lv <email>jinglei.lv&#x00040;sydney.edu.au</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Brain Imaging Methods, a section of the journal Frontiers in Neuroscience</p></fn>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn></author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>16</volume>
<elocation-id>1089886</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Wang, Zhao, Li and Lv.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Wang, Zhao, Li and Lv</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license></permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/24953/multi-dimensional-characterization-of-neuropsychiatric-disorders" ext-link-type="uri">Editorial on the Research Topic <article-title>Multi-dimensional characterization of neuropsychiatric disorders</article-title></related-article>
<kwd-group>
<kwd>neuropsychiatric disorders (NPD)</kwd>
<kwd>NeuroImage</kwd>
<kwd>electroencephalography</kwd>
<kwd>PET</kwd>
<kwd>MRI</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="1"/>
<page-count count="3"/>
<word-count count="1386"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The human nervous system itself and its extensive connections with the human body form a complex system. The individual characteristics and abnormalities of the system can be observed on multiple dimensions, such as the brain functional, structural, molecular, genetic, and behavioral dimensions. Understanding the underlying multi-dimensional mechanisms and the corresponding biomarkers for neuropsychiatric disorders could be regarded as the highest-priority goal in neuroscience and a vital step for clinical practice (Li et al., <xref ref-type="bibr" rid="B1">2019</xref>). In particular, brain disorders can be characterized on multiple dimensions, with reference either to the biomarkers of one modality or to those of multiple modalities. This multi-dimensional method of characterization provides a more objective and accurate identification of disorders; based on this level of precision, treatments can be developed to benefit patients in clinical practice.</p>
<p>This Research Topic assembles 10 articles on a broad spectrum of research in neuropsychiatric disorders. Authors from backgrounds in psychiatry, radiology, computer science, and engineering have all contributed to this Research Topic by conducting empirical studies, developing computational models, performing reviews, and introducing novel intervention techniques. In this Editorial, we provide an overview of these exciting and diverse articles, grouping them based on their conceptual design.</p></sec>
<sec id="s2">
<title>Computational modeling of multi-dimensional brain signals</title>
<p>The modeling scheme proposed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.865594">Lun et al.</ext-link> extracts features of motor imagery EEG signals separately for each hemisphere using a deep learning architecture and then combines the embeddings for classification. This research is helpful for the development of brain&#x02013;machine interfaces for motor functional disability and spinal cord injury. The article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2021.825434">Peng et al.</ext-link> proposes to characterize the neural electrical signals captured by intracranial and scalp EEG on multiple temporal and frequency dimensions so that the rich information can be better utilized for seizure prediction in epilepsy. This is particularly important in surgery-planning for drug-resistant epilepsy. The model proposed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.902528">Liu K. et al.</ext-link> utilizes coupled integration for hierarchical feature representation of MCI and AD with structural MRI to enable improved discrimination of the different stages of AD. Also targeting AD diagnosis but using PET imaging, the article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.831533">Cui et al.</ext-link> proposes a region-by-region descriptor for FDG-PET. The collective descriptors are fed into a novel deep learning network (BMNet) featuring bilinear pooling and metric learning. It transpires that this method offers improved performance in the identification of EMCI and LMCI. This work is important for early diagnosis and intervention in AD.</p></sec>
<sec id="s3">
<title>Multi-dimensional data for treatment development</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.949698">Sun, Guo et al.</ext-link> used an fMRI-derived measure of ALFF to identify potential age differences in the neuropathological mechanism of treatment-resistant depression. An investigation by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.900105">Shadli et al.</ext-link> tested the possibility of using EEG as a biomarker for ketamine therapy in anxiety disorders. Among the signals from multiple electrodes and the frequency spectrum, the authors report right frontal theta power to be a possible biomarker. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.974940">Wu et al.</ext-link> combined rs-fMRI, protein markers, and behavioral assessments to investigate the effect of rTMS on neural plasticity. Although this is a pre-clinical study, it provides evidence for cognitive enhancement that may have future human applications.</p></sec>
<sec id="s4">
<title>Identification and validation of imaging biomarkers of neuropsychiatric disorders</title>
<p>In a study of structural imaging biomarkers, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.949230">Liu T. et al.</ext-link> investigated multiple variables relating to the structural connectome, measured with diffusion MRI. They found that local efficiency of the structural connectome is correlated with language function in infants, suggesting a relationship between language disorders and the early development of white matter in infancy. Functional brain signals also provide an effective approach to the characterization of brain alterations and treatment response. Under the approach proposed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.876121">Sun, Chen et al.</ext-link>, the rich information obtained though rs-fMRI is modeled in the form of regional ReHo and ALFF, resulting in the discovery of functional alteration imaging biomarkers for first-episode and recurrent depression; this finding provides neuroimaging insights into the psychological mechanism of depression. Last but not least, the review article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fnins.2022.812410">Pan et al.</ext-link> revisits the efforts of the psychiatric and neuroimaging community over the course of 40 years to understand the neural substrates of post-stroke depression, covering regional lesion analysis and the study of brain networks, from structural to functional connectome. It is emphasized in this review that multivariate analysis has played an important role in the task, thereby further highlighting the importance of multi-dimensional characterization of the disorder.</p>
<p>In the current Research Topic, most of the articles have devoted efforts to the characterization of neuropsychiatric disorders within a single modality. We envision that, in the near future, it will be possible to measure many of these multi-dimensional modalities in a single patient, so that information across modalities can be integrated to provide a more comprehensive characterization of a particular disorder or spectrum of disorders. Such high-dimensional multi-modal characterization would provide higher discriminability and more accurate digital identification. High-dimensional characterization will become even more powerful if this method can be employed with a large-scale patient cohort, as the big data generated in this way can be fed into machine learning and artificial intelligence systems, enabling an improved understanding of the mechanisms of the disorder in question. As a consequence, we will be able to characterize patient subtypes more precisely and provide personalized diagnoses, resulting in improved treatment and early intervention for neuropsychiatric disorders.</p></sec>
<sec id="s5">
<title>Author contributions</title>
<p>PW: writing&#x02014;original draft. SZ, XL, and JL: writing&#x02014;review and editing. All authors contributed to the article and approved the submitted version.</p></sec>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>This work was supported in part by the National Key R&#x00026;D Program of China under Grant Number: 2020AAA0105702 and the National Natural Science Foundation of China under Grant Numbers: 42271315, 61936007, 82060336, 62036011, and U1801265. Guangdong Basic and Applied Basic Research Foundation (2214050008706), Science and Technology Support Project of Guizhou Province under Grant Number: [2021]432, and Shenzhen Science and Technology Program (JCYJ20220530161409021).</p></sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec sec-type="disclaimer" id="s7">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Guo</surname> <given-names>N.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>Functional neuroimaging in the new era of big data</article-title>. <source>Genom Proteom Bioinformat.</source> <volume>17</volume>:<fpage>393</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.gpb.2018.11.005</pub-id><pub-id pub-id-type="pmid">31809864</pub-id></citation></ref>
</ref-list> 
</back>
</article>
